KatCarney

J Clin Endocrinol Metab. 2005 Sep 27

The Polycystic Ovary Syndrome Associated with Morbid Obesity May Resolve after Weight Loss Induced by Bariatric Surgery.

Conclusions
The polycystic ovary syndrome is a frequent finding in women with morbid obesity, and may resolve after weight loss induced by bariatric surgery.

PRINT OUT THE FULL STUDY HERE:
http://jcem.endojournals.org/cgi/rapidpdf/jc.2005-1490v1

Escobar-Morreale HF, Botella-Carretero JI, Alvarez-Blasco F, Sancho J, San Millan JL.

Department of Endocrinology (H.F.E.-M., J.I.B.-C., F.A.-B. and J.S.) and Molecular Genetics (J.L.S.M.), Hospital Ramon y Cajal, Madrid, Spain.

Context
The polycystic ovary syndrome (PCOS) is frequently associated with obesity. However, there are very few data about PCOS in morbid obesity, especially with regards to its evolution after bariatric surgery.

Objective
To evaluate the response of PCOS to the sustained and marked weight loss achieved by bariatric surgery in morbidly obese women.

Design
Longitudinal prospective nonrandomized evaluation

Settings Academic hospital.

Patients
Thirty-six consecutive premenopausal women submitted to bariatric surgery were screened for PCOS, which was present in seventeen.

Interventions
Bariatric surgery

Main Outcome Measures
Hyperandrogenism, menstrual function and insulin resistance were estimated before and at least six months after bariatric surgery in twelve patients with PCOS.

Results
Weight loss (41 +/- 9 kg after 12 +/- 5 months) was paralleled by a decrease in the hirsutism score (from 9.5 +/- 6.8 to 4.9 +/- 4.2, P = 0.001), total (69 +/- 32 to 42 +/- 19 ng/dL, P < 0.02) and free testosterone (from 1.6 +/- 0.7 to 0.6 +/- 0.3 ng/dL, P < 0.005), androstendione (from 4.1 +/- 1.5 to 3.0 +/- 0.9 ng/mL, P < 0.02) and dehydroepiandrosterone-sulfate (from 2000 +/- 1125 to 1353 +/- 759 ng/mL, P < 0.005), amelioration of insulin resistance estimated by homeostasis model assessment (from 6.0 +/- 3.0 to 1.6 +/- 1.0, P < 0.001) and the restoration of regular menstrual cycles and/or ovulation in all the patients.

PMID: 16189250 [PubMed - as supplied by publisher]

__________________